WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

2026 Biotech Playbook: Hong Kong at the Centre of China's Globalisation Beyond initial listings, Hong Kong increasingly provides durable, repeat access to capital for already-public biotech companies. Unlike the more episodic windows seen els...
(4/16/2026)

A Strategic Playbook for Chinese Biotech Cross... (5/5/2026)

A Biopharmaceutical Superpower: China's Rise, ... (5/1/2026)

China Partnerships Drive Biopharma Deal Surge ... (4/29/2026)

From fast follower to originator: How Asia is ... (4/29/2026)

China Imposes Four-Year Deadline on Conditiona... (4/28/2026)

China Biopharma Financing Rebounds in March as... (4/27/2026)

China Biopharma Deal Activity Slows in Q1 2026... (4/22/2026)

China's Push to Elevate Private Health Insuran... (4/22/2026)

Chinese Biotech Commands One-Third of Global P... (4/21/2026)

China Deepens Opening of Biotech and Healthcar... (4/16/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (4/16/2026)

China's Pharma Innovators Pursue a Range of De... (4/15/2026)

China Clears 14 Novel INDs Last Week, Sp... (5/5/2026) Gyre Thera Closes $300M Cullgen Deal (5/5/2026) U.S. Lawmakers Push to Bar China Clinica... (5/5/2026) Windward Bio Raises $165M to Advance Chi... (5/5/2026) Chinese Insulin Wins FDA Approval, Marki... (5/5/2026) China Tightens Biopharma Supply Chain Co... (5/5/2026) Sinocelltech Advances CD20×CD3 T-Cell E... (5/5/2026) Bambusa Completes Enrollment in Mid-Stag... (5/5/2026) UCB's $2.2B Candid Deal Highlights China... (5/5/2026) Recent Official and Executive Moves (5/1/2026) Shanghai Pharma Completes Exit from Sino... (5/1/2026) EU Approves Henlius–Organon Pertuzumab ... (5/1/2026) China Approves Two Innovative Homegrown ... (5/1/2026) China Pharma Trade Rises 4.22% in Q1 as ... (5/1/2026) CDE Accepts Bayer Filing for FXIa Inhibi... (4/30/2026) Former NMPA Deputy Commissioner Sentence... (4/30/2026) Livzon Takes Control of Vietnam's Imexph... (4/30/2026) Vivacta Bio Raises $50M+ to Advance In V... (4/30/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

UCB's $2.2B Candid Deal Highlights China-Origin Innovat... Windward Bio Raises $165M to Advance China-Origin Asthm... Gyre Thera Closes $300M Cullgen Deal China Pharma Trade Rises 4.22% in Q1 as Exports Shift T... Shanghai Pharma Completes Exit from Sino-US JV with $14...

CDE Opens Consultation on BNCT Drug Development Guideli... CDE Seeks Feedback on Draft Bioanalytical Lab Complianc... China Moves to Expand Maternity Insurance Coverage in D... China NMPA Releases Updated Procedures for Conditional ... CDE Issues New Framework for Post-Approval Changes and ...

China's Basic Medical Insurance Fund Records Strong Sur... China Reports 5.15M New Cancer Cases in 2024, Highlight... China Launches Nationwide Mental Health Coverage Push W... China Moves to Strengthen Community Healthcare and Expa... China Unveils Sweeping Measures to Accelerate Tiered He...

China Tightens Biopharma Supply Chain Controls, Raising... U.S. Lawmakers Push to Bar China Clinical Data From FDA... Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan...

Chinese API Makers Raise Prices as Middle East Conflict... India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as...

Bambusa Completes Enrollment in Mid-Stage Trial of Bisp... Sinocelltech Advances CD20×CD3 T-Cell Engager Into Pha... Chinese Insulin Wins FDA Approval, Marking Breakthrough... China Clears 14 Novel INDs Last Week, Spotlighting Obes... China Approves Two Innovative Homegrown Therapies Ahead...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Former NMPA Deputy Commissioner Sentenced to 14 Years f... Former Jiangxi Provincial Health Commission Chief Dismi... Recent Executive Moves Former Sinopharm Chairman Wei Yulin Sentenced to 12 Yea...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...